2024-04-01 2025-03-31 false Capium Accounts Production 1.1 12084353 2024-04-01 2025-03-31 12084353 bus:AbridgedAccounts 2024-04-01 2025-03-31 12084353 bus:Micro-entities 2024-04-01 2025-03-31 12084353 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 12084353 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12084353 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12084353 2024-04-01 2025-03-31 12084353 2025-03-31 12084353 bus:RegisteredOffice 2024-04-01 2025-03-31 12084353 core:WithinOneYear 2025-03-31 12084353 core:AfterOneYear 2025-03-31 12084353 1 2024-04-01 2025-03-31 12084353 bus:Director1 2024-04-01 2025-03-31 12084353 bus:Director1 2025-03-31 12084353 bus:Director1 2023-04-01 2024-03-31 12084353 bus:Director2 2024-04-01 2025-03-31 12084353 bus:Director2 2025-03-31 12084353 bus:Director2 2023-04-01 2024-03-31 12084353 2023-04-01 12084353 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 12084353 2023-04-01 2024-03-31 12084353 2024-03-31 12084353 core:WithinOneYear 2024-03-31 12084353 core:AfterOneYear 2024-03-31 12084353 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 12084353 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 12084353 bus:OrdinaryShareClass1 2025-03-31 12084353 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 12084353 bus:OrdinaryShareClass1 2024-03-31 12084353 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 12084353 bus:OrdinaryShareClass2 2025-03-31 12084353 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 12084353 bus:OrdinaryShareClass2 2024-03-31 12084353 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 12084353 bus:OrdinaryShareClass3 2025-03-31 12084353 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 12084353 bus:OrdinaryShareClass3 2024-03-31 12084353 core:MotorCars 2024-04-01 2025-03-31 12084353 core:MotorCars 2025-03-31 12084353 core:MotorCars 2024-03-31 12084353 core:ComputerEquipment 2024-04-01 2025-03-31 12084353 core:ComputerEquipment 2025-03-31 12084353 core:ComputerEquipment 2024-03-31 12084353 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 12084353 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 12084353 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 12084353 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 12084353 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 12084353 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 12084353 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 12084353 core:Non-currentFinancialInstruments 2025-03-31 12084353 core:Non-currentFinancialInstruments 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12084353
England and Wales

 

 

 

M S MEDICS LTD



Abridged Accounts
 


Period of accounts

Start date: 01 April 2024

End date: 31 March 2025
  2025   2024
    £ £   £ £
Fixed assets   15,934      19,059 
Current assets 603,014      388,136   
Creditors: amount falling due within one year (67,602)     (48,984)  
Net current assets   535,412      339,152 
Total assets less current liabilities   551,346      358,211 
Provisions for liabilities   (3,028)     (3,621)
Net assets   548,318      354,590 
 

         
Capital and reserves   548,318      354,590 
 
NOTES TO THE ACCOUNTS

General Information
M S Medics Ltd is a private company, limited by shares, registered in England and Wales, registration number 12084353, registration address 2 Manor Court, Manor Mill Lane, Leeds, West Yorkshire, LS11 8LQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 4 (2024 : 4).

3.

Directors' Loan Account

At 31 March 2025, the directors' loan account of £176 (2024: £938) is unsecured, repayable on demand and interest free.
During the year, the directors incurred the following transactions:
Directors' Loan Account   Balance B/Fwd
£
  Advances
£
  Credits
£
  Balance C/F
£
Directors 938  (25,150) 24,388  176 

For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the board of directors on 24 December 2025 and were signed on its behalf by:


--------------------------------
Dr S Venkatesh
Director
1